PlusTherapeuticsInc . (NASDAQ:PSTV) Stock Price Down 37.7%

PlusTherapeuticsInc . (NASDAQ:PSTV)’s share price was down 37.7% on Monday . The company traded as low as $9.00 and last traded at $9.00, approximately 1,517,795 shares traded hands during mid-day trading. An increase of 1,085% from the average daily volume of 128,096 shares. The stock had previously closed at $14.44.

The company has a quick ratio of 0.30, a current ratio of 0.46 and a debt-to-equity ratio of 0.39.

PlusTherapeuticsInc . (NASDAQ:PSTV) last posted its earnings results on Thursday, August 15th. The company reported ($5.12) earnings per share for the quarter, topping analysts’ consensus estimates of ($9.75) by $4.63. PlusTherapeuticsInc . had a negative net margin of 492.45% and a negative return on equity of 240.93%. The firm had revenue of $0.30 million for the quarter.

About PlusTherapeuticsInc . (NASDAQ:PSTV)

Plus Therapeutics, Inc, a clinical-stage pharmaceutical company, engages in developing treatments for cancer and other diseases in the United States. The company's lead product candidate in pipeline is DocePLUS, an albumin-stabilized PEGylated liposomal formulation of docetaxel for the treatment of small cell lung cancer.

Featured Story: Convertible Shares

Receive News & Ratings for PlusTherapeuticsInc . Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PlusTherapeuticsInc . and related companies with's FREE daily email newsletter.